


*In a 30 day, randomized, double-blind, placebo-controlled study of 67 adults, subjects taking 50 mg/day of AprèsFlex® twice daily experienced a statistically significant difference in mean improvements from baseline for joint comfort, stiffness and function as measured by WOMAC that was 7, 5 and 43 times greater in the AprèsFlex® group than placebo, respectively, after 30 days. Statistically significant improvements were seen as early as 5 days.
#“Full potency” is defined as 1500mg glucosamine and 1200mg chondroitin from the National Institutes of Health GAIT trial. Results showed that moderate to severe pain patients had significant improvements compared to the placebo group. This claim is based on SPINS data (52 weeks ending 06/15/25) indicating GNC is the top-selling brand that consistently includes clinical strength doses of glucosamine and chondroitin in every product, unlike other competitors.



